Florida CDMO Receives $106.3M Manufacturing Contract Under Operation Warp Speed

Ology Bioservices, an Alachua, Fla.-based biologics contract development and manufacturing organization (CDMO), has been granted a contract worth up to $106.3 million from the U.S. Army to help out with COVID-19 vaccine and therapeutic production.

Under the contract, Ology Bioservices will reserve production capacity for approximately 186.8 million doses of essential COVID-19 vaccines and therapeutics in support of the Trump administration’s Operation Warp Speed initiative.

The CDMO will also work to support the fill-and-finishing network of Operation Warp Speed, Ology CEO Peter Khoury said.

The company specializes in biologic drug substance manufacturing from early stage through to commercial production and has more than two decades of experience working with the federal government. Ology said that it has been awarded more than $1.8 billion in federal contracts to date. — James Miessler